Latest Multi-drug-resistant tuberculosis Stories
Clinical Activity Of TMC207 shows ATP-Synthase is a Viable Target for treatment of TB MECHELEN, Belgium, June 3 /PRNewswire/ -- Interim results from an ongoing phase 2, randomized, placebo-controlled trial of the investigational drug TMC207 for the treatment of multidrug-resistant tuberculosis (MDR-TB) were published in the New England Journal of Medicine today.
Unique GeneXpert(R) System Capabilities Enable Powerful New TB Diagnostic Tool SUNNYVALE, Calif., April 27 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced the release of Xpert(R) MTB/RIF as a CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices.
Countries in the former Soviet Union and many regions of China are facing an epidemic of multi-drug resistant tuberculosis, according to a new report based on data from 90,000 patients in 83 countries.
According to a study reported in The Lancet on Saturday, a new antibiotic has passed a key phase in a test of drugs aimed at shortening the time to cure tuberculosis, offering a potential boon in the fight against TB.
The discovery of a large number of slow-growing Mycobacterium tuberculosis bacteria, which cause tuberculosis (TB), in the lungs of TB patients could be an important step forward in the design of new anti-TB drugs.
Disease experts claim that efforts to fight HIV and tuberculosis must be paired in order to be most effective.
WASHINGTON, March 24 /PRNewswire-USNewswire/ -- Statement from Stephen J. Nolan, Chairman of the American Lung Association: One hundred and five years after Dr.
U.S. researchers said on Thursday that two existing drugs used in combination appear to offer great promise against the most dangerous form of tuberculosis.
A four-month treatment with the drug rifampin is better tolerated for tuberculosis than the nine-month treatment of isoniazid, Canadian researchers said. Dr.
- The governor of a province or people.